Telmisartan

Common brands: Norliqva, Katerzia, Sdamlo, Aspirin 325, Aspirin 81

Top reporter: Alembic Pharmaceuticals Inc.

Angiotensin 2 Receptor Blocker [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Dihydropyridine Calcium Channel Blocker [EPC]HMG-CoA Reductase Inhibitor [EPC]
17,201
Total Reports
9,048
Serious Reports
1,657
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.63%)

Patient Demographics

Male
6,734
Female
8,484

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Telmisartan.

# Reaction Reports % of Total
1 FATIGUE 1,385
5.4%
2 NAUSEA 1,306
5.1%
3 DRUG INEFFECTIVE 1,200
4.6%
4 DIARRHOEA 1,185
4.6%
5 HEADACHE 1,150
4.5%
6 DYSPNOEA 1,125
4.4%
7 OFF LABEL USE 1,112
4.3%
8 FALL 1,088
4.2%
9 ARTHRALGIA 1,010
3.9%
10 BLOOD PRESSURE INCREASED 958
3.7%
11 DIZZINESS 956
3.7%
12 VOMITING 955
3.7%
13 ASTHENIA 953
3.7%
14 MALAISE 938
3.6%
15 COUGH 909
3.5%
16 HYPERTENSION 881
3.4%
17 PAIN 861
3.3%
18 PNEUMONIA 769
3.0%
19 PYREXIA 766
3.0%
20 PRURITUS 676
2.6%
21 ACUTE KIDNEY INJURY 663
2.6%
22 ABDOMINAL PAIN 628
2.4%
23 DRUG INTERACTION 622
2.4%
24 DECREASED APPETITE 589
2.3%
25 HYPOTENSION 568
2.2%
26 INSOMNIA 543
2.1%
27 NASOPHARYNGITIS 522
2.0%
28 ARTHRITIS 516
2.0%
29 MYALGIA 506
2.0%
30 RASH 490
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.